Manuscripts and Publications

Manuscript
[Anonymous].  2018.  ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS INTERVENTIONS (ATN) DATA HARMONIZATION.
[Anonymous].  0.  ARART Adherence Among HIV-Infected Young Men Who Have Sex with Men: A Multi-Site Daily Diary Study ATN 112.
[Anonymous].  2018.  The association between incarceration and transactional sex among HIV-infected young men who have sex with men in the United States.
[Anonymous].  0.  Associations between cognitive performance and biomarkers of macrophage activation and inflammatory response among HIV-infected youth .
[Anonymous].  0.  ATN 104 Trial 2: Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex with Men.
[Anonymous].  Submitted.  BARRIERS AND FACILITATORS TO THE COLLECTION AND AGGREGATION OF ELECTRONIC HEALTH RECORD HIV DATA: AN ANALYSIS OF STUDY RECRUITMENT VENUES WITHIN THE ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS INTERVENTIONS (ATN).
[Anonymous].  2020.  Correlates of high viral load and adherence among viremic youth in the US enrolled in an adherence improvement intervention.
[Anonymous].  2020.  Design and analysis considerations for a sequentially randomized HIV prevention trial.
[Anonymous].  0.  Employment as HIV prevention: An employment-based intervention for adolescent men who have sex with men and adolescent transgender women of color.
[Anonymous].  0.  Exploring the Heterogeneity of Factors that may Influence Implementation of PrEP in Family Planning Clinics: A Latent Profile Analysis.
[Anonymous].  2018.  Integrating PrEP into Family Planning Services at Title X Clinics in the Southeastern US – Phase 1 (ATN 155).
[Anonymous].  0.  Modeling changes to HIV care among adolescents and young adults in the US during the COVID-19 pandemic.
[Anonymous].  2020.  Precarious Work Involvement among Sexuality Minority and Transgender Youth of Color who are Unemployed or Underemployed in Chicago.
[Anonymous].  2020.  Pre-Exposure Prophylaxis Integration into Family Planning Services at Title X Clinics in the Southeastern United States: A Mixed Methods Hybrid Type I Effectiveness Implementation Study—Phase 2 (ATN 155).
[Anonymous].  0.  Projecting life expectancy for youth with non-perinatally- and perinatally-acquired HIV in the United States.
[Anonymous].  0.  RANDOMIZED CONTROLLED TRIAL OF AN ADHERENCE INTERVENTION IN YOUTH LIVING WITH HIV.
[Anonymous].  2020.  Rates of sexually transmitted infections among US youth with perinatally- and non-perinatally acquired HIV by age, CD4 count and antiretroviral therapy status in three ATN studies.
[Anonymous].  Submitted.  Sexual Partner Characteristics, Relationship Type, and HIV Risk Among A Community Venue-based Sample of Urban Adolescent and Young Adult Men Who Have Sex With Men.
[Anonymous].  0.  State-level clustering in PrEP implementation factors among family planning clinics in the Southern United States.
[Anonymous].  2018.  Triggered Escalating Real-time Adherence Intervention to Promote Rapid HIV Viral Suppression among Youth Living with HIV Failing Antiretroviral Therapy: The TERA Study.
[Anonymous].  2020.  Work2Prevent: Determining the essential components of an employment-focused HIV-prevention intervention for young men who have sex with men (YMSM) and transgender youth of color – Phase 1 (ATN 151).
[Anonymous].  2020.  Work2Prevent: Employment as HIV prevention for young men who have sex with men (YMSM) and transgender youth of color – Phase 2 (ATN 151).
[Anonymous].  2020.  Work2Prevent: Protocol for a community-based employment intervention for preventing HIV risk among young men who have sex with men (YMSM) and transgender youth of color – Phase 3 (ATN 151).
Publication
Belzer ME, MacDonell KKolmodin, Clark LF, Huang J, Olson J, Kahana SY, Naar S, Sarr M, Thornton S.  2015.  Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.. AIDS Patient Care STDS. 29(6):338-45.
Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, M Fernández I, Rutledge B, Martinez J, Garofalo R et al..  2013.  The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.. J Acquir Immune Defic Syndr. 62(4):447-56.
Miller RLin, Reed SJ, Francisco V.  2013.  Accomplishing structural change: identifying intermediate indicators of success.. Am J Community Psychol. 51(1-2):232-42.
Nielsen-Saines K, Mitchell K, Kerin T, Fournier J, Kozina L, Andrews B, Cortado R, Bolan R, Flynn R, Rotheram MJane et al..  2019.  Acute HIV Infection in Youth: Protocol for the Adolescent Trials Network 147 (ATN147) Comprehensive Adolescent Research and Engagement Studies (CARES) Study.. JMIR Res Protoc. 8(1):e10807.
Giovenco D, Muessig KE, Horvitz C, Biello KB, Liu AY, Horvath KJ, Golinkoff JM, Reback CJ, Hightow-Weidman L.  2021.  Adapting technology-based HIV prevention and care interventions for youth: lessons learned across five U.S. Adolescent Trials Network studies.. Mhealth. 7:21.
Belzer ME, MacDonell KKolmodin, Ghosh S, Naar S, McAvoy-Banerjea J, Gurung S, Cain D, Fan CA, Parsons JT.  2018.  Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Message and Cell Phone Support With and Without Incentives: Protocol for a Sequential Multiple Assignment Randomized Trial (SMART).. JMIR Res Protoc. 7(12):e11183.
Chutuape KS, Muyeed AZ, Willard N, Greenberg L, Ellen JM.  2014.  Adding to the HIV Prevention Portfolio - the Achievement of Structural Changes by 13 Connect to Protect Coalitions.. Glob J Community Psychol Pract. 5(2):1-8.
Bauermeister JA, Golinkoff JM, Muessig KE, Horvath KJ, Hightow-Weidman LB.  2017.  Addressing engagement in technology-based behavioural HIV interventions through paradata metrics.. Curr Opin HIV AIDS. 12(5):442-446.
Dietz E, Clum GA, Chung S-E, Leonard L, Murphy DA, Perez LV, Harper GW, Ellen JM.  2010.  Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities.. J Adolesc Health. 46(3):278-83.
Philbin MM, Tanner AE, Ma A, Chambers BD, Ware S, Kinnard EN, Hussen SA, Lee S, J Fortenberry D.  2017.  Adolescent and Adult HIV Providers' Definitions of HIV-Infected Youths' Successful Transition to Adult Care in the United States.. AIDS Patient Care STDS. 31(10):421-427.
Alexander AB, Ott MA, Lally MA, Sniecinski K, Baker A, Zimet GD.  2015.  Adolescent decision making about participation in a hypothetical HIV vaccine trial.. Vaccine. 33(11):1331-7.
Mullins TLKowalczy, Zimet G, Lally M, Kahn JA.  2016.  Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.. AIDS Patient Care STDS. 30(7):339-48.
Starks TJ, Ewing SWFeldstei, Lovejoy T, Gurung S, Cain D, Fan CA, Naar S, Parsons JT.  2019.  Adolescent Male Couples-Based HIV Testing Intervention (We Test): Protocol for a Type 1, Hybrid Implementation-Effectiveness Trial.. JMIR Res Protoc. 8(6):e11186.
Gilbert ALewis, Knopf AS, J Fortenberry D, Hosek SG, Kapogiannis BG, Zimet GD.  2015.  Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research.. J Adolesc Health. 57(1):113-9.
Starks TJ, Dellucci TV, Lovejoy TI, Robles G, Jimenez R, Cain D, Naar S, Ewing SWFeldstei.  2021.  Adolescent Sexual Minority Males, Relationship Functioning, and Condomless Sex.. J Adolesc Health. 68(2):419-421.
Tanner AE, Philbin MM, Ma A, Chambers BD, Nichols S, Lee S, J Fortenberry D.  2017.  Adolescent to Adult HIV Health Care Transition From the Perspective of Adult Providers in the United States.. J Adolesc Health. 61(4):434-439.
Bryson YJ.  2018.  Advances, innovations, and challenges for new and old infections of children and adolescents.. Curr Opin Pediatr. 30(1):100-104.
Bruce D, Harper GW, M Fernández I, Jamil OB.  2012.  Age-concordant and age-discordant sexual behavior among gay and bisexual male adolescents.. Arch Sex Behav. 41(2):441-8.
Murphy DA, Chen X, Naar-King S, Parsons JT.  2012.  Alcohol and marijuana use outcomes in the Healthy Choices motivational interviewing intervention for HIV-positive youth.. AIDS Patient Care STDS. 26(2):95-100.
Bruce D, Kahana S, Harper GW, M Fernández I.  2013.  Alcohol use predicts sexual risk behavior with HIV-negative or partners of unknown status among young HIV-positive men who have sex with men.. AIDS Care. 25(5):559-65.
Gamarel KE, Nelson KM, Stephenson R, Rivera OJSantiago, Chiaramonte D, Miller RLin.  2018.  Anticipated HIV Stigma and Delays in Regular HIV Testing Behaviors Among Sexually-Active Young Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women.. AIDS Behav. 22(2):522-530.
Nichols SL, Bethel J, Kapogiannis BG, Li T, Woods SP, E Patton D, Ren W, Thornton SE, Major-Wilson HO, Puga AM et al..  2016.  Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.. J Neurovirol. 22(2):218-30.
Syed SS, Balluz RS, Kabagambe EK, Meyer WA, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW.  2013.  Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.. AIDS Res Hum Retroviruses. 29(3):493-500.
Boyer CB, Hightow-Weidman L, Bethel J, Li SX, Henry-Reid L, Futterman D, Maturo D, Straub DM, Howell K, Reid S et al..  2013.  An assessment of the feasibility and acceptability of a friendship-based social network recruitment strategy to screen at-risk African American and Hispanic/Latina young women for HIV infection.. JAMA Pediatr. 167(3):289-96.
Philbin MM, Kinnard EN, Tanner AE, Ware S, Chambers BD, Ma A, J Fortenberry D.  2018.  The Association between Incarceration and Transactional Sex among HIV-infected Young Men Who Have Sex with Men in the United States.. J Urban Health. 95(4):576-583.
Saberi P, Neilands TB, Lally MA, Hosek SG, Hightow-Weidman L.  2019.  The Association between Use of Online Social Networks to Find Sex Partners and Sexually Transmitted Infection Diagnosis among Young Men Who Have Sex with Men and Transgender Women Living with HIV.. J Int Assoc Provid AIDS Care. 18:2325958219867324.
Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2013.  Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 57(11):5619-28.
Savel C, Mierzwa S, Gorbach PM, Souidi S, Lally M, Zimet G, Interventions A.  2016.  Avatar Web-Based Self-Report Survey System Technology for Public Health Research: Technical Outcome Results and Lessons Learned.. Online J Public Health Inform. 8(2):e189.
Butame SA, De Leon JM, Lee S-J, Naar S, Genn L, Dark T, Kapogiannis BG.  2021.  Barriers and Facilitators to the Collection and Aggregation of Electronic Health Record HIV Data: An Analysis of Study Recruitment Venues Within the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN).. Eval Health Prof. 44(2):168-176.
MacDonell K, Naar-King S, Huszti H, Belzer M.  2013.  Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.. AIDS Behav. 17(1):86-93.
Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MIsabel, Rubin D.  2016.  Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked To and Engaged in Medical Care.. LGBT Health. 3(2):162-7.
Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML.  2015.  Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.. Sex Transm Dis. 42(5):246-52.
Reed SJ, Miller RLin.  2014.  The Benefits of Youth Engagement in HIV-Preventive Structural Change Interventions.. Youth Soc. 46(4):529-547.
Willard N, Chutuape K, Stines S, Ellen JM.  2012.  Bridging the gap between individual-level risk for HIV and structural determinants: using root cause analysis in strategic planning.. J Prev Interv Community. 40(2):103-17.
Kahn JA, Xu J, Kapogiannis BG, Sleasman JW.  2017.  Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.. J Acquir Immune Defic Syndr. 75(2):241-245.
Ruan A, Tobin NH, Mulligan K, Rollie A, Li F, Sleasman J, Aldrovandi GM.  2016.  Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.. J Acquir Immune Defic Syndr. 72(4):372-5.
Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, Hosek S.  2019.  Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.. J Acquir Immune Defic Syndr. 80(2):160-165.
Steehler K, Siegler AJ.  2019.  Bringing HIV Self-Testing to Scale in the United States: a Review of Challenges, Potential Solutions, and Future Opportunities.. J Clin Microbiol. 57(11)
Sánchez-Cesáreo M, Harper GW, Neubauer L, Cellar D, Doll M, Robles G, Johnson J, Bangi A, Ellen J.  2008.  Building bridges between organization development and community psychology: An integrative model for multi-site community based research. Interamerican Journal of Psychology. :1-10.
W Comulada S.  2021.  Calculating level-specific SEM fit indices for multilevel mediation analyses.. Stata J. 21(1):195-205.
Sill AM, Kreisel K, Deeds BGriffin, Wilson CM, Constantine NT, Peralta L.  2007.  Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections.. J Clin Lab Anal. 21(1):40-5.
Pennar AL, Dark T, Simpson KN, Gurung S, Cain D, Fan C, Parsons JT, Naar S.  2019.  Cascade Monitoring in Multidisciplinary Adolescent HIV Care Settings: Protocol for Utilizing Electronic Health Records.. JMIR Res Protoc. 8(5):e11185.
Lin AJ, Dudek JC, Francisco VT, Castillo M, Freeman P, Martinez M, Sniecinski K, Young K, Ellen JM.  2012.  Challenges and approaches to mobilizing communities for HIV prevention among young men who have sex with men of color.. J Prev Interv Community. 40(2):149-64.
Havens PL, Perumean-Chaney SE, Patki A, Cofield SS, Wilson CM, Liu N, Anderson PL, Landovitz RJ, Kapogiannis BG, Hosek SG et al..  2020.  Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.. Clin Infect Dis. 70(4):687-691.
Reisner SL, Jadwin-Cakmak L, Hughto JMWhite, Martinez M, Salomon L, Harper GW.  2017.  Characterizing the HIV Prevention and Care Continua in a Sample of Transgender Youth in the U.S.. AIDS Behav. 21(12):3312-3327.
Clum GA, Andrinopoulos K, Muessig K, Ellen JM.  2009.  Child abuse in young, HIV-positive women: linkages to risk.. Qual Health Res. 19(12):1755-68.
Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM et al..  2009.  Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.. Hum Genet. 126(5):685-96.
Parsons JT, Starks T, Gurung S, Cain D, Marmo J, Naar S.  2019.  Clinic-Based Delivery of the Young Men's Health Project (YMHP) Targeting HIV Risk Reduction and Substance Use Among Young Men Who Have Sex with Men: Protocol for a Type 2, Hybrid Implementation-Effectiveness Trial.. JMIR Res Protoc. 8(5):e11184.
Chen X, Murphy DA, Naar-King S, Parsons JT.  2011.  A clinic-based motivational intervention improves condom use among subgroups of youth living with HIV.. J Adolesc Health. 49(2):193-8.
Mullins TLKowalczy, Lally M, Zimet G, Kahn JA.  2015.  Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.. AIDS Patient Care STDS. 29(4):193-203.
GW H, OB J, BDM W.  2008.  Collaborative Community-Based Research as Activism: Giving Voice and Hope to Lesbian, Gay, and Bisexual Youth. Journal of Gay and Lesbian Psychotherapy,. 11:99-100.
Havens PL, Hazra R.  2015.  Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.. Pediatr Infect Dis J. 34(4):406-8.
Lee S-J, Ocasio MA, Goldbeck CS, Koussa M, Comulada WScott, Swendeman D, Klausner JD, Rotheram-Borus MJane.  2020.  Community-based Implementation of Centers for Disease Control and Prevention's Recommended Screening for Sexually Transmitted Infections Among Youth at High Risk for HIV Infection in Los Angeles and New Orleans.. Sex Transm Dis. 47(7):481-483.
Shannon CLee, Koussa M, Lee S-J, Fournier J, Abdalian SEllen, Rotheram MJane, Klausner JD.  2019.  Community-Based, Point-of-Care Sexually Transmitted Infection Screening Among High-Risk Adolescents in Los Angeles and New Orleans: Protocol for a Mixed-Methods Study.. JMIR Res Protoc. 8(3):e10795.
Naar S, Robles G, MacDonell KKolmodin, Dinaj-Koci V, Simpson KN, Lam P, Parsons JT, K Sizemore M, Starks TJ.  2020.  Comparative Effectiveness of Community-Based vs Clinic-Based Healthy Choices Motivational Intervention to Improve Health Behaviors Among Youth Living With HIV: A Randomized Clinical Trial.. JAMA Netw Open. 3(8):e2014650.
Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P et al..  2018.  Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.. Clin Infect Dis. 66(2):213-219.
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Torres CMRivera, Chutuape KS, Stines SJ, Straub DM et al..  2014.  A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.. J Adolesc Health. 55(6):765-73.
Lee S, Kapogiannis BG, Flynn PM, Rudy BJ, Bethel J, Ahmad S, Tucker D, Abdalian SEllen, Hoffman D, Wilson CM et al..  2013.  Comprehension of a simplified assent form in a vaccine trial for adolescents.. J Med Ethics. 39(6):410-2.
Nichols SL, Lowe A, Zhang X, Garvie PA, Thornton S, Goldberger BA, Hou W, Goodenow MM, Sleasman JW.  2014.  Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.. Drug Alcohol Depend. 134:376-382.
Miller RLin, Reed SJ, Francisco VT, Ellen JM.  2012.  Conflict transformation, stigma, and HIV-preventive structural change.. Am J Community Psychol. 49(3-4):378-92.
Simoni JM, Tapia K, Lee S-J, Graham SM, Beima-Sofie K, Mohamed ZH, Christodoulou J, Ho R, Collier AC.  2020.  A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.. AIDS Behav. 24(4):1226-1236.
Reed SJ, Miller RLin.  2013.  Connect to protect and the creation of AIDS-competent communities.. AIDS Educ Prev. 25(3):255-67.
Ziff MA, Willard N, Harper GW, Bangi AK, Johnson J, Ellen JM.  2010.  Connect to Protect Researcher-Community Partnerships: Assessing Change in Successful Collaboration Factors over Time.. Glob J Community Psychol Pract. 1(1):32-39.
Horvath KJ, MacLehose RF, Martinka A, DeWitt J, Hightow-Weidman L, Sullivan P, Amico KR.  2019.  Connecting Youth and Young Adults to Optimize Antiretroviral Therapy Adherence (YouTHrive): Protocol for a Randomized Controlled Trial.. JMIR Res Protoc. 8(7):e11502.
Straub DM, Arrington-Sanders R, D Harris R, Willard N, Kapogiannis B, Emmanuel P, Futterman D, Ellen JM.  2011.  Correlates of HIV testing history among urban youth recruited through venue-based testing in 15 US cities.. Sex Transm Dis. 38(8):691-6.
Tarantino N, Brown LK, Whiteley L, M Fernández I, Nichols SL, Harper G.  2018.  Correlates of missed clinic visits among youth living with HIV.. AIDS Care. 30(8):982-989.
Bruce D, Bauermeister JA, Kahana SY, Mendoza E, M Fernández I.  2018.  Correlates of Serodiscordant Condomless Anal Intercourse Among Virologically Detectable HIV-Positive Young Men Who Have Sex with Men.. AIDS Behav. 22(11):3535-3539.
Saberi P, Mayer K, Vittinghoff E, Naar-King S.  2015.  Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.. AIDS Behav. 19(1):93-103.
Neilan AM, Bulteel AJB, Hosek SG, Foote JHA, Freedberg KA, Landovitz RJ, Walensky RP, Resch SC, Kazemian P, A Paltiel D et al..  2020.  Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States.. Clin Infect Dis.
da Silva DTeixeira, Biello K, Lin WY, Valente PK, Mayer KH, Hightow-Weidman L, Bauermeister JA.  2021.  COVID-19 Vaccine Acceptance among an Online Sample of Sexual and Gender Minority Men and Transgender Women.. Vaccines (Basel). 9(3)
Castillo M, Palmer BJ, Rudy BJ, Fernandez MIsabel.  2012.  Creating partnerships for HIV prevention among YMSM: the Connect Protect® Project and House and Ball Community in Philadelphia.. J Prev Interv Community. 40(2):165-75.
Miller RLin, Janulis PF, Reed SJ, Harper GW, Ellen J, Boyer CB.  2016.  Creating Youth-Supportive Communities: Outcomes from the Connect-to-Protect® (C2P) Structural Change Approach to Youth HIV Prevention.. J Youth Adolesc. 45(2):301-15.
Harper GW, Jadwin-Cakmak L, Cherenak E, Wilson P.  2019.  Critical Consciousness-Based HIV Prevention Interventions for Black Gay and Bisexual Male Youth.. Am J Sex Educ. 14(1):109-133.
Gamarel KE, Nichols S, Kahler CW, Westfall AO, Lally MA, Wilson CM.  2018.  A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.. Sex Transm Infect. 94(4):304-308.
Ellen JM, Greenberg L, Willard N, Stines S, Korelitz J, Boyer CB.  2015.  Cross-sectional survey comparing HIV risk behaviours of adolescent and young adult men who have sex with men only and men who have sex with men and women in the U.S. and Puerto Rico.. Sex Transm Infect. 91(6):458-61.
Christodoulou J, Abdalian SEllen, Jones ASK, Christodoulou G, Pentoney SL, Rotheram-Borus MJane.  2020.  Crystal Clear with Active Visualization: Understanding Medication Adherence Among Youth Living with HIV.. AIDS Behav. 24(4):1207-1211.
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N et al..  2017.  Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.. Clin Infect Dis. 64(3):317-325.

Pages